AKR1C3 Back

aldo-keto reductase family 1, member C3 (3-alpha hydroxysteroid dehydrogenase, type II)

External References:      Wikipedia GeneCards HUGO COSMIC Google Scholar

NCBI Description of AKR1C3

This gene encodes a member of the aldo/keto reductase superfamily, which consists of more than 40 known enzymes and proteins. These enzymes catalyze the conversion of aldehydes and ketones to their corresponding alcohols by utilizing NADH and/or NADPH as cofactors. The enzymes display overlapping but distinct substrate specificity. This enzyme catalyzes the reduction of prostaglandin (PG) D2, PGH2 and phenanthrenequinone (PQ), and the oxidation of 9alpha,11beta-PGF2 to PGD2. It may play an important role in the pathogenesis of allergic diseases such as asthma, and may also have a role in controlling cell growth and/or differentiation. This gene shares high sequence identity with three other gene members and is clustered with those three genes at chromosome 10p15-p14. Three transcript variants encoding different isoforms have been found for this gene.

Community Annotation of AKR1C3 Add / Edit AKR1C3: Annotations

No community annotations yet for AKR1C3.
Sort mutations by: Tumor type  Mutation type  Position  
Straightedge cursor Expand

Figure notes


• "Mouse over" a mutation to see details.
• Missense green saturation indicates evolutionary conservation of the mutated positions.
• Red hashes in protein strip are splice sites.
• Blue-white-red bars are log2 copy ratio distributions (–1 to +1) from Zack et al. (2013).


Legend

AKR1C3 is highly significantly mutated in
(none)
AKR1C3 is significantly mutated in
(none)
AKR1C3 is near significance in
(none)

Click on a tumor type to see its full list of significant genes.

Data details


Mutation list for AKR1C3